This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2837) Opioid and Related Substance Misuse (173) Substance Abuse (470)

Published on in Vol 6, No 6 (2022): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16996, first published .
Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

Authors of this article:

Suzanne K Vosburg1 Author Orcid Image ;   Taryn Dailey-Govoni1 Author Orcid Image ;   Jared Beaumont1 Author Orcid Image ;   Stephen F Butler1 Author Orcid Image ;   Jody L Green1 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. Barbosa J, Leal S, Pereira F, Dinis-Oliveira R, Faria J. Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving. Pharmaceuticals 2023;16(1):86 View
  2. Pchelintsev M. Assessing the risks of abuse of opioids in real-world data. Real-World Data & Evidence 2023;3(1):30 View
  3. Carpenter K, Nguyen A, Smith D, Samori I, Humphreys K, Lembke A, Kiang M, Eichstaedt J, Altman R, Villanueva C. Which social media platforms facilitate monitoring the opioid crisis?. PLOS Digital Health 2025;4(4):e0000842 View